Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
419 studies found for:    "Emtricitabine"[TREATMENT] AND HIV [CONDITION]
Show Display Options
Download search resultsDownload the search results for:
"Emtricitabine"[TREATMENT] AND HIV [CONDITION] (419 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed An Open-Label Study of Emtricitabine in Combination With Other Antiretroviral Agents in HIV Infected Pediatric Subjects
Condition: HIV Infections
Intervention: Drug: Emtricitabine
2 Completed Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Condition: HIV Infections
Interventions: Drug: Emtricitabine/Tenofovir disoproxil fumarate;   Drug: Tenofovir disoproxil fumarate
3 Completed Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)
Condition: HIV Infection
Interventions: Drug: Tenofovir, Emtricitabine, Lopinavir/r;   Drug: Tenofovir, Emtricitabine, Raltegravir
4 Completed Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects
Condition: HIV Infections
Interventions: Drug: darunavir/ritonavir QD + raltegravir BID;   Drug: darunavir/r QD + tenofovir/emtricitabine QD (fixed dose combination)
5 Completed
Has Results
Safety, Tolerability and Pharmacokinetics of Efavirenz in HIV-Infected Children
Condition: HIV Infections
Intervention: Drug: Efavirenz (EFV) + Didanosine (ddI) + Emtricitabine (FTC)
6 Completed Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate
7 Completed
Has Results
Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)
Conditions: Acute HIV Infection;   HIV Infections
Intervention: Drug: efavirenz, emtricitabine, and tenofovir
8 Active, not recruiting Switch From Nevirapine-based Regimen to Once a Day Rilpivirine/Emtricitabine/Tenofovir
Condition: HIV
Intervention: Drug: Rilpivirine/Emtricitabine/Tenofovir
9 Completed Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
Condition: HIV Infections
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Placebo
10 Completed
Has Results
The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)
Condition: HIV Infections
Intervention: Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
11 Completed
Has Results
Raltegravir + Lopinavir/Ritonavir or Emtricitabine/Tenofovir for HIV Treatment Naive Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir & Lopinavir/ritonavir;   Drug: Raltegravir and emtricitabine/tenofovir
12 Completed GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
Condition: HIV Infections
Interventions: Drug: Truvada (TDF+FTC) alone;   Drug: FTC alone;   Procedure: No HAART
13 Completed Efficacy of Treatment Intensification With Maraviroc on HIV-1 Viral Latency in Recently Infected Hiv-1 naïve Patients Starting Raltegravir Plus Tenofovir/Emtricitabine
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Maraviroc;   Drug: Tenofovir/Emtricitabine
14 Completed Tenofovir DF (Disoproxil Fumarate) in Combination With Emtricitabine in HIV-1 Patients
Condition: HIV Infections
Interventions: Drug: Truvada (tenofovir DF + emtricitabine);   Drug: Emtriva (emtricitabine);   Drug: Viread (tenofovir DF)
15 Completed A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study
Condition: HIV Infections
Interventions: Drug: Emtricitabine 200mg - Tenofovir 300mg;   Drug: Abacavir 600mg - Lamivudine 300mg
16 Unknown  HIV Persistence and Viral Reservoirs
Conditions: HIV;   HIV Infections
Intervention: Drug: Raltegravir, tenofovir/emtricitabine
17 Completed
Has Results
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
Condition: HIV Infection
Interventions: Drug: emtricitabine/tenofovir;   Drug: abacavir/lamivudine
18 Completed Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
Conditions: HIV Infection;   Pregnancy
Interventions: Drug: Tenofovir (TDF);   Drug: Emtricitabine (FTC)
19 Completed Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject
Condition: HIV Infection
Interventions: Drug: Darunavir/Ritonavir;   Drug: Lamivudine;   Drug: Emtricitabine/tenofovir or abacavir/lamivudine
20 Unknown  Emtricitabine Given Once A Day With Other Anti-HIV Drugs in Children With HIV
Condition: HIV Infections
Interventions: Drug: Lopinavir/Ritonavir;   Drug: Emtricitabine;   Drug: Stavudine

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.